| Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis … G Otar Yener, A Paç Kısaarslan, K Ulu, E Atalay, F Haşlak, S Özdel, ... Rheumatology International 42 (5), 879-889, 2022 | 41 | 2022 |
| Differences and similarities of multisystem inflammatory syndrome in children, Kawasaki disease and macrophage activating syndrome due to systemic juvenile idiopathic arthritis … GO Yener, AP Kısaarslan, K Ulu, E Atalay, F Haşlak, S Özdel, BB Yücel, ... Rheumatology international 42 (5), 879, 2021 | 38 | 2021 |
| The clinical course and short-term health outcomes of multisystem inflammatory syndrome in children in the single pediatric rheumatology center B Sözeri, Ş Çağlayan, V Atasayan, K Ulu, T Coşkuner, Ö Pelin Akbay, ... Postgraduate medicine 133 (8), 994-1000, 2021 | 30 | 2021 |
| The clinical course of SARS-CoV-2 infection among children with rheumatic disease under biologic therapy: a retrospective and multicenter study B Sozeri, K Ulu, U Kaya-Akça, F Haslak, A Pac-Kisaarslan, G Otar-Yener, ... Rheumatology international 42 (3), 469-475, 2022 | 21 | 2022 |
| Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19 Ş Çaǧlayan, HE Sönmez, G Otar Yener, E Baǧlan, K Öztürk, K Ulu, ... Frontiers in pediatrics 10, 942455, 2022 | 15 | 2022 |
| POS1181 CLINICAL COURSE OF COVID-19 IN CHILDREN WITH RHEUMATIC DISEASE UNDER BIOLOGIC THERAPY F Demir, K Ulu, Ş Çağlayan, T Coşkuner, B Sözeri Annals of the Rheumatic Diseases 80 (Suppl 1), 871-872, 2021 | 13 | 2021 |
| Real-life data on efficacy and safety of original Adalimumab and biosimilar Adalimumab (ABP 501) in pediatric rheumatic diseases K Ulu, M Çakan, Ş Çağlayan, RE Yiğit, F Demir, T Coşkuner, E Kardeş, ... Expert Opinion on Biological Therapy 23 (8), 833-839, 2023 | 10 | 2023 |
| The multifaceted presentation of the multisystem inflammatory syndrome in children: data from a cluster analysis HE Sönmez, Ş Çağlayan, G Otar Yener, EZ Başar, K Ulu, M Çakan, ... Journal of clinical medicine 11 (6), 1742, 2022 | 10 | 2022 |
| Toward the integration of biosimilars into pediatric rheumatology: adalimumab ABP 501 experience of PeRA research group FG Demirkan, K Ulu, K Öztürk, ŞG Karadağ, S Özdel, HE Sönmez, ... Expert opinion on biological therapy 22 (2), 197-202, 2022 | 9 | 2022 |
| PREDICT-crFMF score: a novel model for predicting colchicine resistance in children with familial Mediterranean fever N Aktay Ayaz, FG Demirkan, T Coşkuner, F Demir, A Tanatar, M Çakan, ... Modern Rheumatology 34 (1), 220-225, 2024 | 7 | 2024 |
| Chronic recurrent multifocal osteomyelitis: A multidisciplinary experience of 22 pediatric cases with a mean follow-up of 27 months E Okay, K Ulu, F Demir, T Sari, S Zeynalov, ANT Yildirim, B Baysal, ... Journal of Orthopaedic Science 28 (2), 438-445, 2023 | 7 | 2023 |
| Towards a standardized program of transitional care for adolescents with juvenile idiopathic arthritis for Turkey: a national survey study B Sözeri, N Şahin, C Açarı, PO Avar Aydın, O Baba, E Bağlan, ... Pediatric Rheumatology 22 (1), 7, 2024 | 6 | 2024 |
| Vasculitis Working Party of the Pediatric Rheumatology European Society (PReS). Clinical features, treatment and outcome of pediatric patients with severe cutaneous … M Sestan, N Kifer, B Sozeri, F Demir, K Ulu, CA Silva, RT Campos, ... Semin Arthritis Rheum 61, 152209, 2023 | 5 | 2023 |
| Çocukluk çağı zehirlenmelerinin geriye dönük değerlendirilmesi ve maliyet analizi K Ulu, CH Akkuş, ŞE Ulu, İT Erkum, SO Cebeci Journal of Child 19 (3), 138-147, 2019 | 5 | 2019 |
| Clinical features, treatment and outcome of pediatric patients with severe cutaneous manifestations in IgA vasculitis: multicenter international study M Sestan, N Kifer, B Sozeri, F Demir, K Ulu, CA Silva, RT Campos, ... Seminars in arthritis and rheumatism 61, 152209, 2023 | 4 | 2023 |
| The assessment of autoinflammatory disease classification criteria (Eurofever/PRINTO) in a real-life cohort Ş Çağlayan, G Mardinoğlu, MH Yarar, K Ulu, T Coşkuner, RE Yiğit, ... Clinical Rheumatology 42 (6), 1645-1653, 2023 | 4 | 2023 |
| Clinical characteristics and predictors for recurrence in chronic nonbacterial osteomyelitis: a retrospective multicenter analysis K Ulu, R İşgüder, ŞG Karadağ, E Bağlan, GK Kayaalp, GO Yener, ... Turkish Journal of Medical Sciences 53 (5), 1105-1111, 2023 | 4 | 2023 |
| A rare onset in tumour necrosis factor receptor–associated periodic syndrome: recurrent macrophage activation syndrome triggered by COVID-19 infection Ş Çağlayan, K Ulu, M Çakan, B Sözeri Rheumatology 61 (12), e366-e367, 2022 | 3 | 2022 |
| Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis on anti-interleukin-1 or-6 therapy K Ulu, E Aliyev, E Kılıç Könte, A Tanatar, Ş Türkmen, Ş Doğantan, ... Rheumatology, keae124, 2024 | 2 | 2024 |
| Not easy-peasy to diagnose: familial Mediterranean fever unaccompanied by fever SD Arık, GK Kayaalp, V Guliyeva, FG Demirkan, A Tanatar, Ö Akgün, ... European Journal of Pediatrics 182 (9), 3983-3988, 2023 | 2 | 2023 |
